Back to results
US 11,766,415 B2Granted
Reducing triglyceride levels and cortisol levels with pharmaceutical preparations
AssigneeGlykon Technologies Group, LLC
InventorDaniel E. Clouatre
Life of this patent
Estimating the term…
Abstract
The invention relates generally to the field of medical treatment. More particularly, the invention relates to treating a subject in order to reduce levels of triglycerides or cortisol by the administration of pharmaceutical formulations.
Claims19
A method of treating a subject for a health condition associated with a high triglyceride level, the method comprising:
- determining a first triglyceride level in the subject;
- administering HCA to the subject, wherein HCA is (−)-hydroxycitric acid or a salt thereof;
- and
- determining a second triglyceride level in the subject between 10 minutes and 600 minutes after the administering,
- wherein the second triglyceride level is determined be lower than the first triglyceride level, thereby treating the subject for the health condition associated with high triglyceride levels.
2 more elements
A method of treating a subject for a health condition associated with a high cortisol level, the method comprising:
- determining a first cortisol level in the subject;
- administering HCA to the subject, wherein HCA is (−)-hydroxycitric acid or a salt thereof;
- and
- determining a second cortisol level in the subject between 10 minutes and 600 minutes after the administering,
- wherein the second cortisol level is determined be lower than the first cortisol level, thereby treating the subject for the health condition associated with high cortisol levels.
2 more elements
Dependencies are inferred from the claim text.